Temsirolimus is a promising immunomodulatory agent for enhanced transplantation outcomes.

Saved in:
Bibliographic Details
Title: Temsirolimus is a promising immunomodulatory agent for enhanced transplantation outcomes.
Authors: Li X; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Peng Z; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., An K; Department of Physiology, Xuzhou Medical University, Xuzhou 221009, China., Xue M; Division of Ophthalmology and Vision Science, Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China., Wang Z; Department of Pharmacy, Zhoukou Central Hospital, Zhoukou 466000, China., Xia J; Organ Transplantation Institute, Fujian Provincial Key Laboratory of Organ and Tissue Regeneration, School of Medicine, Xiamen University, Xiamen 361100, China. Electronic address: yxyyz@gxu.edu.cn., Qi Z; Medical College of Guangxi University, Guangxi University, Nanning 530004, China. Electronic address: xia@xmu.edu.cn., Shu X; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: sxg678@hust.edu.cn.
Source: Transplant immunology [Transpl Immunol] 2023 Dec; Vol. 81, pp. 101952. Date of Electronic Publication: 2023 Oct 31.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first